Galleria mellonella native and analogue peptides Gm1 and ΔGm1. II) Anti-bacterial and anti-endotoxic effects  by Correa, Wilmar et al.
Biochimica et Biophysica Acta 1838 (2014) 2739–2744
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bbamemGalleria mellonella native and analogue peptides Gm1 and ΔGm1. II)
Anti-bacterial and anti-endotoxic effectsWilmar Correa a, Marcela Manrique-Moreno a, Jochen Behrends b, Edwin Patiño a, Chakravarthy Marella b,
Carlos Peláez-Jaramillo a, Patrick Garidel c, Thomas Gutsmann b, Klaus Brandenburg b, Lena Heinbockel b,⁎
a Instituto de Química, Facultad de Ciencias Exactas y Naturales, Universidad de Antioquia, AA. 1226, Medellín, Colombia.
b Forschungszentrum Borstel, Division of Biophysics, Parkallee 10, 23845 Borstel, Germany
c Universität Halle-Wiienberg, Institut für Physikalische Chemie, Von-Danckelmann-Platz 4, 06120 Halle/Saale, GermanyAbbreviations: AMPs, antimicrobial peptides; Gm ce
mellonella; Gm1, native peptide; AFM, atomic force micro
lipopolysaccharides; PCP, phenol/chloroform/petrol ether;
tumour necrosis factor-α; MIC, minimum inhibitory con
albumin
⁎ Corresponding author at: Forschungszentrum Bo
Parkallee 10, 23845, Germany. Tel.: +49 4537 1882350; f
E-mail addresses: wilcova@gmail.com (W. Correa), mm
(M. Manrique-Moreno), jbehrends@fz-borstel.de (J. Behre
epatino@matematicas.udea.edu.co (E. Patiño), cmarella@f
directorgiem@gmail.com (C. Peláez-Jaramillo), Patrick.Ga
(P. Garidel), tgutsmann@fz-borstel.de (T. Gutsmann), kbr
(K. Brandenburg), lheinbockel@fz-borstel.de (L. Heinbock
http://dx.doi.org/10.1016/j.bbamem.2014.07.005
0005-2736/© 2014 Elsevier B.V. All rights reserved.a b s t r a c ta r t i c l e i n f oArticle history:
Received 22 October 2013
Received in revised form 25 June 2014
Accepted 1 July 2014






Galleria mellonellaAntimicrobial peptides (AMPs) are important components of the innate immune system of animals, plants, fungi
and bacteria and are recently under discussion as promising alternatives to conventional antibiotics. We have
investigated two cecropin-like synthetic peptides, Gm1, which corresponds to the natural overall uncharged
Galleria mellonella native peptide and ΔGm1, a modiﬁed overall positively charged Gm1 variant. We have
analysed these peptides for their potential to inhibit the endotoxin-induced secretion of tumour necrosis
factor-α (TNF-α) from humanmononuclear cells. Furthermore, in a conventional microbiological assay, the abil-
ity of these peptides to inhibit the growth of the rough mutant bacteria Salmonella entericaMinnesota R60 and
the polymyxin B-resistant Proteus mirabilis R45 was investigated and atomic force microscopy (AFM) measure-
ments were performed to characterize the morphology of the bacteria treated by the two peptides. We have
also studied their cytotoxic properties in a haemolysis assay to clarify potential toxic effects.
Our data revealed for both peptides minor anti-inﬂammatory (anti-endotoxin) activity, but demonstrated anti-
microbial activity with differences depending on the endotoxin composition of the respective bacteria. In accor-
dancewith the antimicrobial assay, AFMdata revealed a strongermorphology change of the R45 bacteria than for
the R60. Furthermore, Gm1 had a stronger effect on the bacteria than ΔGm1, leading to a different morphology
regarding indentations and coalescing of bacterial structures. The ﬁndings verify the biophysical measurements
with the peptides on model systems. Both peptides lack any haemolytic activity up to an amount of 100 μg/ml,
making them suitable as new anti-infective agents.cropin D-like peptide, Galleria
scopy; PMB, polymyxin B; LPS,
MNC, mononuclear cells; TNF-α,
centration; BSA, bovine serum
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Infectious diseases represent a major challenge in medical science,
exacerbated by the increase of resistant microbes. It demands immedi-
ate measures, such as a more stratiﬁed treatment of patients by the
existing drugs and the development of new antibiotics [1,2]. Indepen-
dent of this fact, a main issue is that conventional antibiotics can causecell lysis during bacterial killing, leading to a release of endotoxins (lipo-
polysaccharides, LPS) from the outer membrane of Gram-negative bac-
teria. This release can lead to a worsening of the patients' health status
due to an increase in inﬂammation [3]. Released LPS is one of the most
potent activators of the human immune system and may cause sepsis,
severe sepsis and septic shock [4]. Therefore, one main demand is the
development of drugs which are able to neutralize bacterial endotoxins
[5]. One approach may be the use of antimicrobial peptides (AMPs),
which may combine the effects of microbial killing and endotoxin neu-
tralization. For example, some insect species can express an individual
set of AMPs in response to invading microorganisms, which may also
exert anti-endotoxin activity [6,7]. Here, we focus on host defence
AMPs from insects [8,9], which are thought to act by a rapid destruction
of bacterial membranes [10,11]. A particular species Galleria mellonella
(G. mellonella) concurrently produces an impressive array of at least
18 known or putative AMPs from 10 families to defend against invading
microbes, which may also exert anti-endotoxin activity [12,13]. Gm1, a
native peptide with no net charge obtained from G. mellonella, is the
peptide with the broadest activity spectrum, which has proven activity
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(E. coli) D31 as well as ﬁlamentous fungi [14]. We have taken Gm1 as
a promising candidate peptide for elucidating its ability to neutralize
the toxic properties of LPS components of the outer membrane of
Gram-negative bacteria [15], to kill bacteria and to analyse the killing
mechanism. As a modiﬁed structure the compound ΔGm1 was investi-
gated,which is overall positively charged due to an exchange of 5 amino
acids to cationic ones. In this second part of two manuscripts, we focus
on the elucidation of the biologic activity of the two peptides. Therefore
we investigated the microbial susceptibility in a conventional minimal
inhibitory concentration assay, performed a comprehensive study of
themorphology of the bacteria in the presence of the peptides by atom-
ic force microscopy and tested their LPS-neutralizing activity in an
in vitro assay of LPS cell stimulation by analysing the peptide induced
inhibition of the secretion of TNF-α.
2. Materials and methods
2.1. LPS and peptides
LPS Ra (R60) and Re (R595) from Salmonella entericaMinnesota and
R45 from polymyxin B-resistant Proteus mirabilis were extracted from
the bacteria by phenol/chloroform/petrol ether (PCP) method [16],
puriﬁed and the composition was analysed using Maldi-TOF mass
spectrometry. The chemical structures of the S. enterica LPS are drawn
schematically in Fig. 1.
The puriﬁcation and characterization of the native peptide Gm1
(ENFFKEIERA GQRIRDAIISAAPAVETLAQAQKIIKGGD) were described
for the ﬁrst time in previous publications [14,17]. The peptides Gm1
and ΔGm1 (ENFFKEKERKGQRIRDAIIS RRPRVETLAQAQKIIKGGD) were
synthesized without an amidated C-terminus by the Fmoc solid-phase
synthesis technique with an automatic peptide synthesizer (433 A
Applied Biosystems Synjthesizer).
2.2. Determination of the TNF-α expression after stimulation of human cells
with endotoxin
Mononuclear cells (MNC)were isolated fromheparinized peripheral
blood taken from healthy donors. Therefore 100 ml of whole blood
was mixed in a 1:1 ratio with Hanks Balanced Salt Solution (Gibco,
Invitrogen, California, USA). The mixture was subdivided in 33 ml
portions and each was added to 10 ml Biocoll separation solution
(Merck, Darmstadt, Germany). The density gradient centrifugation
was performed at 4 °C for 30 min at 600 ×g. The supernatant was re-
moved and the turbid MNC layer was transferred in 2 50 ml plastic
tubes. To the supernatants Hanks solution was added until a ﬁnal vol-
ume of 50 ml was reached. The tubes were centrifuged at 4 °C with
400 ×g for 10min. The supernatants were discarded, the cell pellets re-
suspended in 5ml Hanks solution each and combined in 1 50ml tube. 2Fig. 1. Schematic representation of the rough type lipopolysaccharides R60 and R595 from
Salmonella enterica.further washing cycles with Hanks solution and 1 cycle with RPMI
medium 1640 (Biochrom AG, Berlin, Germany) containing 2 mM
L-glutamine, 100 U/ml penicillin and 100 μg/ml streptomycin were per-
formed before the cells were resuspended in 10 ml RPMI medium. The
cell number was equilibrated at 5 × 106 MNC/ml with RPMI medium.
For stimulation, 200 μl/well MNC was transferred into 96-well culture
plates. LPS-stimuli was serially diluted in RPMI 1640without antibiotics
and added to the cultures at 20 μl perwell to obtain aﬁnal concentration
of 1 ng/ml (0.23 nM). Afterwards the peptides were added to the
cultures at ﬁnal concentrations of 100 ng/ml (Gm1 23.5 nM; ΔGm1
21.8 nM). The cultures were incubated for 4 h at 37 °C under 5% CO2.
Cell-free supernatants were collected after centrifugation of the culture
plates for 10min at 400 ×g and stored at−20 °C until determination of
the cytokine content. Immunological determination of TNF-α was
performed in duplicate as described in the protocol (OptEIA; BD,
Heidelberg, Germany).
Statistical analysis was performed using GraphPad Prism 5 software
(GraphPad Software, La Jolla, CA). Data of 4 individual healthy donors
were compared by the Student two-tailed t test (*p b 0.05).
2.3. Minimal inhibitory concentration
The determination of the minimal inhibitory concentration (MIC)
was performed in compliance with the method described by the
EuropeanCommittee for Antimicrobial Susceptibility Testing [18]. Brief-
ly, the bacteria were grown in a preculture overnight at 37 °C gently
shaken. 1 ml of the culture was transferred to 49 ml lysogeny broth
medium (LB; Merck, Darmstadt, Germany) until an OD600 of 0.7 was
reached. The bacteria are adjusted to 1 × 106 bacteria/ml suspension
and 10 μl was transferred to a 96well plate loadedwith 90 μl of the pep-
tide solutions in 20 mM HEPES pH 7.4. The plate was incubated over-
night at 37 °C under constant gentle shaking, subsequently the OD620
was measured in a Tecan Reader inﬁniteM200Pro. Three independent
experiments were performed and the mean value was calculated. The
MIC (minimal inhibitory concentration) was deﬁned as the lowest
peptide concentration at which no bacterial growth was measurable.
Experiments were repeated three times and the shown results repre-
sent the MICs with and error of one dilution step.
2.4. Atomic force microscopy (AFM)
The alterations in the bacterial cell surface caused by Gm1 and
ΔGm1 were investigated using the AFM MFP-3D (Asylum Research,
Santa Barbara, CA, U.S.A.). Brieﬂy, exponential-phase bacterial cultures
(5 × 108 CFU/ml of P. mirabilis R45 and S. enterica R60 in 100 μl of
LB medium) were incubated without additives, BSA (100 μg/mL)
and melittin (10 μM) as negative and positive controls or peptides
(10 μg/ml), respectively. The additives plus bacteria were incubated
at 37 °C for 30 min. Then 50 μl of bacterial suspension was placed
on mica, excess of liquid was removed and the bacteria were air-
dried at room temperature for 24 h. Subsequently the samples were
rinsed with 3 ml di-water to remove salt crystals, dried again and im-
aged with a CSG 11 cantilever (k = 0.1 N/m; NT-MDT) in contact
mode, using line-frequencies of 1.0 Hz and 512 points per lines. Fur-
ther image processing (ﬂattening and plane ﬁtting) was done with the
MFP-3D software under IGOR Pro (Lake Oswego, OR, U.S.A.). Images
shown here are representative of the respective samples. All samples
were repeated three times in independent experiments.
2.5. Haemolytic activity of peptides
Freshly isolated human erythrocytes were obtained from
citrated human blood of 3 individual healthy donors by centrifugation
(1500 ×g, 10 min), washed three times with isotonic PBS buffer,
pH 7.4 at 37 °C and suspended in the same buffer. The activity of the
peptides to lyse human erythrocytes was determined by dilutions
Table 1
Minimal inhibitory concentration (MIC) of Gm1 and ΔGm1 to different enterobacteriaceae.
Bacteria Gm1 (μM) ΔGm1 (μM)
S. enterica R60 40 N160
S. enterica R595 b1.25 20
P. mirabilis R45 5 N160
E. coli Re b2.5 20
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of erythrocytes (5 × 108 cells/ml) was incubated with 80 μl of a peptide
sample at 37 °C for 30 min in a humidiﬁed box. The haemolytic activity
after incubation was measured by transferring the supernatants into
another empty microtiter plate. The optical density was measured in a
plate reader at 405 nm. Haemolytic activity was expressed as percent-
age of released haemoglobin with respect to water controls (100%
release) or controls processed without peptides (0% release). Shown
results are averages of three independent experiments.
3. Results
3.1. Inhibition of the production of cytokines from human mononuclear
cells
The LPS-induced production of TNF-α from human mononuclear
cells was determined and the potential inhibition by the addition of
Gm1 and ΔGm1 at a LPS/peptide ratio of 1:100 wt.% (Fig. 2). Both pep-
tides caused a minor inhibition of the LPS-induced TNF-α secretion,
with the peptide Gm1 showing a statistically signiﬁcant and slightly
higher inhibition of LPS R60 than ΔGm1. This suggests that Gm1 and
ΔGm1 can block the action of free endotoxin partially, however, the
level of the inhibition is moderate.
3.2. Antibacterial activity
In order to compare the antibacterial activity of Gm1 and ΔGm1, we
used four different rough mutant enterobacteria. S. entericaMinn. R60,
R595, E. coli Re and P. mirabilis R45 representing different negatively
charged LPS backbones with the longest carbohydrate chain in the
R60 and the deep roughmutants R595, Re and R45, which differ mainly
in substitutions of aminoarabinose, with the highest negative charge for
the Re, then the R595 and with the lowest overall charge for the R45
(Table 1). Gm1 outperforms ΔGm1 in all cases, which seems to be sur-
prising due to the fact that the latter has 5 positive charges assumed
to bind better to the negatively charged LPS backbones than the overall
uncharged compound Gm1.
3.3. Morphological changes of bacterial surfaces after Gm1 and ΔGm1
treatment: imaging by AFM
We focused our AFM analyses on the P. mirabilis R45 strain in order
to see the morphological changes of a polymyxin B-resistant strain
induced by the action of peptides [19,20]. This strain displays a
chemotype of LPS that has a non-stoichiometric substitution of anFig. 2. LPS R60 (1 ng)-induced TNF-α expression from human MNC in the absence and
presence of peptide Gm1 and ΔGm1 (100 ng) was determined. 4 independent experi-
ments were performed and compared by the use of the Stundent t test (*p b 0.05).amino-arabinose, which leads to a reduction of the negative net charge
as compared to LPS R595 or LPS R60 (Fig. 1) [21,22]. For this we used
BSA and mellitin as a negative and positive control respectively. The
concentration of melittin used was reported in a previous work to be
close at the MIC value found for this strain in presence of 20 mM
Hepes, pH 7.4, and 150 mM NaCl, supplemented with 10% LB medium
[23]. This concentration allows us to compare theMIC values of the pep-
tides studied here. The AFM data, obtained at Gm1 and ΔGm1 concen-
trations of 10 μM, revealed subtle changes caused on the bacterial cell
surface with high-resolution and low-distortion images and it has
been employed for elucidating the interaction of the peptide NK-2
with E. coli and P.mirabilisR45 [23]. Effects of Gm1 andΔGm1 treatment
on themorphology of the bacteria assessed by AFM are shown in Figs. 3
and 4. A normal morphology of the membrane surfaces and a good
deﬁnition of borders between bacteria and also lysed cells resulted
from the normal process of growth (Figs. 3 and 4A, B). P. mirabilis R45
exhibits a tendency to form clusters of cells itself, while S. enterica R60
is distributed rather individually.
Gm1 shows a drastic impact on the structural integrity of both bac-
teria (Figs. 3 and 4D). It led to a different morphology, indentations
and a loss of cytoplasm was observed. However, the most considerable
observationwas the apparent fusion ofmembranes, which led to a blur-
ring of the borders between single bacteria. The picture represented by
ΔGm1 not only differs from Gm1, but an increased attachment of the
cells to each other was also observed (Fig. 4E). However, the treatment
of the two peptides led to a different effect on the bacteria, then the
strong cell disrupting peptide melittin, whereby for the former the ef-
fect can be described as predominantly clotting and membrane fusing
and for the latter as cell lysing.
3.4. Haemolysis of Gm1 and ΔGm1
Asmeasure for the results reﬂects the assumed differences in the in-
teraction mechanisms and corroborate our biophysical ﬁndings, that
Gm1 is a stronger inducer of bacterial destructions, which leads to dis-
solution of the single bacteria. Possible cytotoxic activity of the peptides,
Gm1 and ΔGm1 were analysed in a haemolysis assay to test the ability
to lyse erythrocytes. The highest concentration of 199 μg/ml of each
tested peptide does not show any sign of cytotoxicity, whereas synthet-
ic bee venom melittin, as well-known positive control, exhibits already
at rather low concentrations of essential haemolytic activity (Fig. 5).
4. Discussion
In the present study, we investigated the biological activity of two
peptides, the natural peptide, Gm1 and the overall-positively charged
variant, ΔGm1, whereby the focus was on the interaction with Gram-
negative bacteria.
The biophysical analysis of the interaction of the peptides with rele-
vant lipids from the outer membrane of Gram-negative bacteria, i.e.,
negatively charged dimyristoylphosphatidylglycerol and lipopolysac-
charides (LPS)was performed in a preceding study.We showed consid-
erable differences between the two peptides, Gm1 led to a ﬂuidization
of the acyl chains of the lipids in themacromolecular structures, where-
as ΔGm1 had a rigidifying effect on these. Furthermore, the binding
characteristics of the peptide to the bacterial LPS revealed differences.
While both peptides provided similar values for the Gibbs free energy
Fig. 3. AFM images of alterations in the S. enterica R60 cell surface. The bacteria were
incubated without (control) (A) or in the presence of BSA (100 μg/ml) (B) or melittin
(10 μM) (C). S. enterica R60 cell surface after incubation with Gm1 and ΔGm1 (10 μM)
are shown in (E) and (D) respectively. The left panels show deﬂection images and the
right panels are 3D reconstructions. The images were performed in air in contact mode.
Fig. 4. AFM images of alterations in the P. mirabilis R45 cell surface. The bacteria were in-
cubated without (control) (A) or in the presence of BSA (100 μg/ml) (B) or mellitin (10
μM) (C). P. mirabilis R45 cell surface after incubation with Gm1 and ΔGm1 (10 μM) are
shown in (D) and (E) respectively. The left panels show deﬂection images and the right
panels are 3D reconstructions. The images were performed in air in contact mode.
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the entropic effect (−TΔS). Surprisingly, the enthalpy of the LPS
interaction was stronger for Gm1, while the entropy effect seems to
be more pronounced for ΔGm1. The impact of these differences is
reﬂected by the biologic activity regarding the neutralization of LPS,
the antimicrobial activity, the haemolytic activity and the direct obser-
vation of bacteria by atomic force microscopy.
The LPS-neutralizing effect observed for both peptides can be de-
scribed as rather weak compared to known anti-LPS peptides [24,25].A statistically signiﬁcant effect could be shown for the neutralization
of Gm1 from LPS, but the overall difference between both peptides ap-
pears to be small. However, more prominent is the antimicrobial activ-
ity of the peptide, Gm1 demonstrated an effect against S. enterica and
E. coli, with a better activity against the deep-rough mutant than to
the rough mutant, as expected. Remarkably, antimicrobial activity is
better pronounced against the polymyxin-resistant P. mirabilis. An ex-
planation could be that the Gm1 peptide has no overall net charge
whereas polymyxin B is positively charged, like the large majority of
Fig. 5. Haemolytic activity of samples Gm1 and ΔGm1 in comparison to melittin, an
extensively studied haemolytic peptide .
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addition of aminoarabinose to the negatively charged LPS molecule to
reduce the net charge and therefore the binding strength of the antimi-
crobial peptide. The antimicrobial activity of ΔGm1 turned out to be
negligible.
Extended information about the antimicrobial activity is gained by
the morphological changes, monitored by AFM. For the control peptide
melittin, with a known strong antimicrobial activity [23], membrane
disruption and blebs could be observed frequently associated with a
spreading out of the cytosolic contents. Similar observations were
made for other AMPs with membrane attacking actions [23,27,28].
The picture for Gm1 and ΔGm1 is markedly different (Figs. 3 and 4).
Both peptides demonstrated a clotting effect on the S. enterica rough
type bacteria, with a slightly pronounced consequence for Gm1 (Fig. 3
D, E). P. mirabilismay reveal similar clotting effects, but this is hard to
identify, because of the regular tendency of the bacteria to stack togeth-
er. Nonetheless theAFM images reveal differences in the agglomeration,
whichmight be discussed asmembrane fusion effects. This is expressed
by a complete dissolution of the single bacterial cells leading to one un-
structured assembly, in which the single bacterial cells lose their indi-
vidual shapes (Figs. 3 and 4D,E). The manner of bacterial killing,
accompanied with a formation of cell clusters, could be an interesting
observation with regard to the release of free toxins from the cell sur-
face. The aspect of endotoxin release during antibiotic treatment is a fre-
quently observed phenomenon [3], which could be reduced by the
detected effects. Thus, AFM represents a direct non-optical technique,
which is able to monitor sensitively already slight changes in the mor-
phology of bacterial cells.
The next step could be to study the action of the peptides Gm1 and
ΔGm1 also in an animalmodel of infection. It is important to note, how-
ever, that the use of peptides systemically, in particular against bacterial
sepsis, is hampered by a possible cytotoxicity of peptides, as described
for others [29-31]. As a good prevision of probably no cytotoxicity of
the analysed peptides could be the hint that in our in vitro experiments
no signiﬁcant haemolysis up to 100 μg/ml per used peptide could be
detected. Therefore the peptides Gm1 and ΔGm1 seem to be suitable
for medical systemic use.Acknowledgements
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